(9CI)-2,3-二氢-噻吩并[2,3-c]吡啶 | 117103-46-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩并吡啶类
• 中文名称: (9CI)-2,3-二氢-噻吩并[2,3-c]吡啶
• 英文名称: 2,3-dihydrothieno<2,3-c>pyridine
• 英文别名: 2,3-Dihydrothieno[2,3-c]pyridine
• CAS: 117103-46-5
• 化学式: C₇H₇NS
• 分子量: 137.205
• InChiKey: SJNUXEAPCYTTDZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  38.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (9CI)-2,3-二氢-噻吩并[2,3-c]吡啶 生成 噻吩[2,3-C]并吡啶
  参考文献：
  名称：

  BRAYE, E.;OLLIVIER, J. -M.

  摘要：

  DOI：
• 作为产物：
  描述：

  2-but-3-ynylsulfanylpyrazine;2,2,2-trifluoroacetic acid 以73%的产率得到
  参考文献：
  名称：

  GEURTSEN, BART;DE, BIE DICK A.;VAN, DER PLAS HENK C., TETRAHEDRON, 45,(1989) N0, C. 6519-6530

  摘要：

  DOI：

文献信息

• FUSED HETEROPOLYCYCLIC COMPOUND, AND METHOD FOR PRODUCING CONDUCTIVE POLYMER IN WHICH SAID COMPOUND IS USED
  申请人：SHOWA DENKO K.K.

  公开号：US20190337919A1

  公开（公告）日：2019-11-07

  The present invention relates to a fused heteropolycyclic compound represented by formulae (1) and (2), a method for producing the same, and a method for producing a conductive polymer represented by formulae (3) and (4) in which at least one compound represented by formula (2) is used (the symbols in the formulae are as described in the description). The method of the present invention is a method for producing a sulfo-group-containing polyisothianaphthene capable of reducing the use amount of an oxidant or capable of being polymerized without the use of any oxidant.

  本发明涉及由式（1）和（2）表示的融合杂多环化合物，其制备方法，以及由式（3）和（4）表示的至少使用一种由式（2）表示的化合物生产的导电聚合物的制备方法（公式中的符号如描述中所述）。本发明的方法是一种生产含有磺酸基的聚异噻纳芘的方法，该方法能够减少氧化剂的使用量或者在不使用任何氧化剂的情况下进行聚合。
• Intramolecular Diels-Alder reactions of quaternary pyrazinium salts and protonated pyrazinium cations. Synthesis of annelated pyridinium salts and annelated pyridines.
  作者：Bart Geurtsen、Dick A. de Bie、Henk C. van der Plas

  DOI：10.1016/s0040-4020(01)89528-4

  日期：1989.1

  quaternary pyrazinium salts as well as the protonated pyrazines undergo an intramolecular Diels-Alder reaction under considerably milder conditions than the corresponding neutral pyrazines. The products of the reactions were []-annelated quaternary pyridinium salts and []-annelated protonated pyridinium cations, respectively.

  如13 C NMR数据所示，炔基取代的吡嗪在二氯甲烷中用四氟硼酸三乙基氧鎓进行季铵化仅在N-4处产生3-炔基-1-乙基吡嗪鎓盐。同样的吡嗪与三氟乙酸的质子化也发生在N-4处。季吡嗪鎓盐以及质子化的吡嗪在比相应的中性吡嗪温和得多的条件下进行分子内Diels-Alder反应。反应产物分别为[ ]-退火的季吡啶鎓盐和[ ]-退火的质子化吡啶鎓阳离子。
• [EN] HERBICIDAL PYRIMIDINE COMPOUNDS<br/>[FR] COMPOSÉS HERBICIDES DE PYRIMIDINE
  申请人：BASF SE

  公开号：WO2018019554A1

  公开（公告）日：2018-02-01

  The present invention relates to the pyrimidine compounds of formula (I), or their agriculturally acceptable salts or derivatives as herbicides, wherein the variables are defined according to the description, use of pyrimidine compounds of formula (I) as herbicides, compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one pyrimidine compound of the formula (I) to act on plants, their seed and/or their habitat.

  本发明涉及公式（I）的嘧啶化合物，或其在农业上可接受的盐或衍生物作为除草剂，其中变量根据说明书定义，使用公式（I）的嘧啶化合物作为除草剂，包含它们的组合物以及它们作为除草剂的用途，即用于控制有害植物，还涉及一种控制不受欢迎的植被的方法，其中包括允许至少一种公式（I）的嘧啶化合物的除草有效量作用于植物、它们的种子和/或它们的生境。
• [EN] HERBICIDAL TRIAZINE COMPOUNDS<br/>[FR] COMPOSÉS HERBICIDES DE TRIAZINE
  申请人：BASF SE

  公开号：WO2019141552A1

  公开（公告）日：2019-07-25

  The present invention relates to the triazine compounds of formula (I), or their agriculturally acceptable salts or derivatives as herbicides, wherein the variables are defined according to the description, use of triazine compounds of formula (I) as herbicide, compositions comprising them and their use as herbicides, i.e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of at least one triazine compounds of the formula (I) to act on plants, their seed and/or their habitat.

  本发明涉及公式（I）的三嗪类化合物，或其在农业上可接受的盐或衍生物作为除草剂，其中变量根据说明定义，使用公式（I）的三嗪类化合物作为除草剂，包括它们的组成物和它们作为除草剂的使用，即用于控制有害植物，同时还提供一种控制不受欢迎的植被的方法，该方法包括允许至少一种公式（I）的除草剂有效量作用于植物、它们的种子和/或它们的栖息地。
• 7-Substituted bicyclic pyrazolidinones
  申请人：ELI LILLY AND COMPANY

  公开号：EP0202046A1

  公开（公告）日：1986-11-20

  7-Substituted bicyclic pyrazolidinone compounds as antimicrobials and the corresponding intermediates, are discussed or provided. The use of the antimicrobial compounds in pharmaceutical compositions and in methods for treating bacterial infections is set forth. The pyrazolidinone compounds are of the formula wherein one of R1 and R2 is hydrogen, halo, C1 to C6 alkyl, C1 to C6 substituted alkyl, perfluoro C2 to C4 alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, a heterocyclic ring, nitro or cyano; a group of the formula wherein X is fluoro, chloro, bromo or iodo; a group of the formula wherein z is 0, 1 or 2 and R7 is C1 to C6 alkyl, C1 to C6 substituted alkyl, phenyl, substituted phenyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl or a heterocyclic ring; a group of the formula wherein R8 is hydrogen, C1 to C6 alkyl, C, to C6 substituted alkyl, perfluoro C2 to C4 alkyl, trihalomethyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, amino, (monosubstituted)amino, or (disubstituted)amino; a group of the formula wherein R9 is hydrogen, an organic or inorganic cation, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, a carboxy-protecting group, or a non-toxic, metabolically-labile, ester-forming group; a group of the formula wherein R10 is hydrogen, an organic or inorganic cation, C1 to C5 alkyl, C, to G6 aubatituted allcyl, C7 to C12 arylalkyl, C7 to C12 aubatltuted arylalkyl, phenyl, or substituted phenyl; a group of the formula ⊕ wherein -N≡Q is a quaternary ammonium group; or a group of the formula -CH2-S-Heterocycllc ring; a group of the formula wherein R11 is hydrogen, C1 to Ce alkyl, C, to Ce substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl or C1 to C7 acyl; or a group of the formula wherein R12 and R13 are the same or different and are hydrogen, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl, C1 to C7 acyl, or a group of the formula; wherein Rq is C, to C6 alkyl, C7 to C12 arylalkyl or phenyl; and the other of R, and R2 is a group of the formula wherein R14 is hydrogen, an organic or inorganic cation, a carboxy-protecting group or a non-toxic, metabolically-labile ester-forming group; and R3 and R4 are the same or different and are hydrogen, C1 to C6 alkyl, C1 to C6 substituted alkyl, C7 to C12 arylalkyl, C7 to C12 substituted arylalkyl, phenyl, substituted phenyl or a group of the formula wherein R15 has the same definition as R9; R5 and R6 are: 1) each hydrogen, an amino protecting group; or acyl group derived from a C, to C30 carboxylic acid; provided that at least one of Rs and R6 must be hydrogen; or 2) taken together to form a phthalimido group; or a pharmaceutically-acceptable salt thereof.

  讨论或提供了作为抗菌剂的 7-取代双环吡唑烷酮化合物及相应的中间体。阐述了抗菌化合物在药物组合物和治疗细菌感染方法中的用途。吡唑烷酮化合物的结构式如下 其中 R1 和 R2 之一为氢、卤素、C1 至 C6 烷基、C1 至 C6 取代烷基、全氟 C2 至 C4 烷基、C7 至 C12 芳烷基、C7 至 C12 取代芳烷基、苯基、取代苯基、杂环、硝基或氰基； 式中的基团 其中 X 是氟、氯、溴或碘； 式中的基团 其中 z 是 0、1 或 2，R7 是 C1 至 C6 烷基、C1 至 C6 取代的烷基、苯基、取代的苯基、C7 至 C12 芳烷基、C7 至 C12 取代的芳烷基或杂环； 式中的基团 其中 R8 是氢、C1 至 C6 烷基、C, 至 C6 取代的烷基、全氟 C2 至 C4 烷基、三卤甲基、C7 至 C12 芳烷基、C7 至 C12 取代的芳烷基、苯基、取代的苯基、氨基、(单取代)氨基或(二取代)氨基； 式中的基团 其中 R9 是氢、有机或无机阳离子、C1～C6 烷基、C1～C6 取代的烷基、C7～C12 芳烷基、C7～C12 取代的芳烷基、苯基、取代的苯基、羧基保护基团或无毒、代谢上易腐烂的酯形成基团； 式中的基团 其中 R10 是氢、有机或无机阳离子、C1 至 C5 烷基、C, 至 G6 亚氨基全烷基、C7 至 C12 芳烷基、C7 至 C12 亚氨基芳烷基、苯基或取代苯基； 式中的基团 ⊕ 其中-N≡Q 是季铵基团；或式中-CH2-S-杂环的基团； 式中的基团 其中 R11 是氢、C1 至 Ce 烷基、C1 至 Ce 取代的烷基、C7 至 C12 芳烷基、C7 至 C12 取代的芳烷基、苯基、取代的苯基或 C1 至 C7酰基；或式中的基团 其中 R12 和 R13 相同或不同，并且是氢、C1 至 C6 烷基、C1 至 C6 取代的烷基、C7 至 C12 芳烷基、C7 至 C12 取代的芳烷基、苯基、取代的苯基、C1 至 C7酰基或式中的基团； 其中 Rq 是 C 至 C6 烷基、C7 至 C12 芳烷基或苯基；以及 R 和 R2 中的另一个是式中的基团 其中 R14 是氢、有机或无机阳离子、羧基保护基团或无毒、可代谢的成酯基团； R3 和 R4 相同或不同，并且是氢、C1 至 C6 烷基、C1 至 C6 取代的烷基、C7 至 C12 芳烷基、C7 至 C12 取代的芳烷基、苯基、取代的苯基或式中的一个基团。 其中 R15 的定义与 R9 相同； R5 和 R6 为 1) 各为氢、氨基保护基；或由 C 至 C30 羧酸衍生的酰基； 但 Rs 和 R6 中至少有一个必须是氢；或 2) 结合在一起形成邻苯二甲酰亚胺基团；或其药学上可接受的盐。